Literature DB >> 19406864

Left ventricular mass increase is associated with cognitive decline and dementia in the elderly independently of blood pressure.

Angelo Scuteri1, Roberta Coluccia, Lorenzo Castello, Edoardo Nevola, Anna Maria Brancati, Massimo Volpe.   

Abstract

AIMS: Left ventricular (LV) mass increase is considered part of composite target organ damage in hypertension and an independent risk factor for cardiovascular (CV) events. This study was designed to explore whether left ventricular mass index (LVMI) is associated with cognitive decline and dementia in elderly subjects, independently of blood pressure (BP) levels. METHODS AND
RESULTS: Four hundred subjects (mean age 79 +/- 6 years) were studied. Left ventricular mass was measured echocardiographically in accordance with American Society of Echocardiography and normalized for body height to the 2.7 (LVMI). Global cognitive function was evaluated with the mini-mental state examination (MMSE) (maximum score 30). Dementia was defined as an MMSE score <21. Arterial stiffness was evaluated as carotid-femoral pulse wave velocity by Complior. Prevalence of hypertension was 70% and diabetes mellitus was diagnosed in 25%. No significant differences in traditional CV risk factors were observed across LVMI quartiles. Mini-mental state examination showed an inverse trend across LVMI quartiles (the higher the LVMI, the lower the MMSE, P for trend <0.05); systolic and diastolic BP levels were not different across LVMI quartiles. In multivariable logistic regression models, including age, sex, BP levels, and use of antihypertensive drugs as covariates, the highest LVMI was found to be independently associated with a two-fold higher likelihood of having dementia. The association persisted significant even after adjustment for arterial stiffness.
CONCLUSION: In elderly subjects, LVMI is associated with a progressive cognitive decline. This association is independent of BP levels and/or large artery stiffness.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19406864     DOI: 10.1093/eurheartj/ehp133

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  22 in total

Review 1.  Bringing prevention in geriatrics: evidences from cardiovascular medicine supporting the new challenge.

Authors:  Angelo Scuteri; Edward G Lakatta
Journal:  Exp Gerontol       Date:  2012-03-03       Impact factor: 4.032

2.  Neurocognition in treatment-resistant hypertension: profile and associations with cardiovascular biomarkers.

Authors:  Patrick J Smith; James A Blumenthal; Alan L Hinderliter; Stephanie M Mabe; Jeanne E Schwartz; Forgive Avorgbedor; Andrew Sherwood
Journal:  J Hypertens       Date:  2019-05       Impact factor: 4.844

Review 3.  Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association.

Authors:  Philip B Gorelick; Angelo Scuteri; Sandra E Black; Charles Decarli; Steven M Greenberg; Costantino Iadecola; Lenore J Launer; Stephane Laurent; Oscar L Lopez; David Nyenhuis; Ronald C Petersen; Julie A Schneider; Christophe Tzourio; Donna K Arnett; David A Bennett; Helena C Chui; Randall T Higashida; Ruth Lindquist; Peter M Nilsson; Gustavo C Roman; Frank W Sellke; Sudha Seshadri
Journal:  Stroke       Date:  2011-07-21       Impact factor: 7.914

4.  Association of left ventricular hypertrophy with cognitive decline and dementia risk over 20 years: The Atherosclerosis Risk In Communities-Neurocognitive Study (ARIC-NCS).

Authors:  Faye L Norby; Lin Y Chen; Elsayed Z Soliman; Rebecca F Gottesman; Thomas H Mosley; Alvaro Alonso
Journal:  Am Heart J       Date:  2018-08-02       Impact factor: 4.749

5.  Left Ventricular Hypertrophy and Remodeling and Risk of Cognitive Impairment and Dementia: MESA (Multi-Ethnic Study of Atherosclerosis).

Authors:  Kasra Moazzami; Mohammad Reza Ostovaneh; Bharath Ambale Venkatesh; Mohammadali Habibi; Kihei Yoneyama; Colin Wu; Kiang Liu; Isabel Pimenta; Annette Fitzpatrick; Steven Shea; Robyn L McClelland; Susan Heckbert; Rebecca F Gottesman; David A Bluemke; Timothy M Hughes; João A C Lima
Journal:  Hypertension       Date:  2018-01-29       Impact factor: 10.190

Review 6.  Cardiovascular fitness and structural brain integrity: an update on current evidence.

Authors:  Tracy d'Arbeloff
Journal:  Geroscience       Date:  2020-08-07       Impact factor: 7.713

Review 7.  Is the Brain an Early or Late Component of Essential Hypertension?

Authors:  John Richard Jennings; Matthew F Muldoon; Alan F Sved
Journal:  Am J Hypertens       Date:  2020-05-21       Impact factor: 2.689

8.  Objective cardiac markers in dementia: results from the Kerala-Einstein study.

Authors:  S Buss; M L Noone; R Tsai; B Johnson; V G Pradeep; K A Salam; P S Mathuranath; J Verghese
Journal:  Int J Cardiol       Date:  2012-10-23       Impact factor: 4.164

9.  Left Ventricular Mass, Brain Magnetic Resonance Imaging, and Cognitive Performance: Results From the Strong Heart Study.

Authors:  Bernhard Haring; Adam Omidpanah; Astrid M Suchy-Dicey; Lyle G Best; Steven P Verney; Dean K Shibata; Shelley A Cole; Tauqeer Ali; Barbara V Howard; Dedra Buchwald; Richard B Devereux
Journal:  Hypertension       Date:  2017-09-11       Impact factor: 10.190

10.  Left ventricular hypertrophy and cognitive function: a systematic review.

Authors:  C Restrepo; S K Patel; V Rethnam; E Werden; J Ramchand; L Churilov; L M Burrell; A Brodtmann
Journal:  J Hum Hypertens       Date:  2018-01-12       Impact factor: 3.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.